R&G PharmaStudies Co., Ltd. (SHE:301333)
48.91
-1.22 (-2.43%)
At close: Jun 2, 2026
-0.49% (1Y)
| Market Cap | 4.69B +7.4% |
| Revenue (ttm) | 896.26M +21.2% |
| Net Income | 133.65M -6.7% |
| EPS | 1.40 -6.5% |
| Shares Out | 95.99M |
| PE Ratio | 34.90 |
| Forward PE | 28.27 |
| Dividend | 0.16 (0.32%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 1,398,813 |
| Open | 50.20 |
| Previous Close | 50.13 |
| Day's Range | 48.55 - 50.20 |
| 52-Week Range | 43.50 - 91.78 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |